Media Room

Second quarter 2023 results

Second quarter 2023 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A session.

Press releases

October 2, 2023
Media Update: Sanofi presents new data from robust MS clinical pipeline exploring multiple approaches to address important unmet patient needs
September 29, 2023
Media Update: Sanofi completes acquisition of Qunol®
September 26, 2023
Press Release: Dupixent® (dupilumab) sBLA for treatment of eosinophilic esophagitis in children aged 1 to 11 accepted for FDA Priority Review

Contact our media team

You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.

For any other request, please call the switchboard: +33 1 53 77 40 00


Half Year 2023 Financial Report XBRL Package
Download PDF
Half Year 2023 Financial Report
Download PDF
First quarter 2023 results
Download PDF
Fourth quarter and full year 2022 results
Download PDF

Email Alerts

Subscribe to our email alerts to receive our press releases.